Medical Student, University of Michigan Medical School, Ann Arbor, MI.
Research Analyst, Michigan Opioid Prescribing Engagement Network, Ann Arbor, MI.
Ann Surg. 2018 Aug;268(2):271-276. doi: 10.1097/SLA.0000000000002308.
We sought to determine the correlation between the probability of postoperative opioid prescription refills and the amount of opioid prescribed, hypothesizing that a greater initial prescription yields a lower probability of refill.
Although current guidelines regarding opioid prescribing largely address chronic opioid use, little is known regarding best practices and postoperative care.
We analyzed Optum Insight claims data from 2013 to 2014 for opioid-naïve patients aged 18 to 64 years who underwent major or minor surgical procedures (N = 26,520). Our primary outcome was the occurrence of an opioid refill within 30 postoperative days. Our primary explanatory variable was the total oral morphine equivalents provided in the initial postoperative prescription. We used logistic regression to examine the probability of an additional refill by initial prescription strength, adjusting for patient factors.
We observed that 8.67% of opioid-naïve patients refilled their prescriptions. Across procedures, the probability of a single postoperative refill did not change with an increase with initial oral morphine equivalents prescribed. Instead, patient factors were correlated with the probability of refill, including tobacco use [odds ratio (OR) 1.42, 95% confidence interval (CI) 1.23-1.57], anxiety (OR 1.30, 95% CI 1.15-1.47), mood disorders (OR 1.28. 95% CI 1.13-1.44), alcohol or substance abuse disorders (OR 1.43, 95% CI 1.12-1.84), and arthritis (OR 1.21, 95% CI 1.10-1.34).
The probability of refilling prescription opioids after surgery was not correlated with initial prescription strength, suggesting surgeons could prescribe smaller prescriptions without influencing refill requests. Future research that examines the interplay between pain, substance abuse, and mental health could inform strategies to tailor opioid prescribing for patients.
我们旨在确定术后阿片类药物处方续用的概率与处方阿片类药物用量之间的相关性,假设初始处方量越大,续用的概率越低。
尽管目前关于阿片类药物处方的指南主要涉及慢性阿片类药物使用,但对于最佳实践和术后护理知之甚少。
我们分析了 2013 年至 2014 年期间接受大手术或小手术的 18 至 64 岁阿片类药物初治患者(N=26520)的 Optum Insight 理赔数据。我们的主要结局是在术后 30 天内发生阿片类药物续用。我们的主要解释变量是初始术后处方中提供的总口服吗啡当量。我们使用逻辑回归来检查初始处方强度与额外续用的概率,同时调整患者因素。
我们观察到,8.67%的阿片类药物初治患者续用了他们的处方。在各种手术中,单次术后续用的概率并没有随着初始口服吗啡当量的增加而增加。相反,患者因素与续用的概率相关,包括吸烟(比值比[OR]1.42,95%置信区间[CI]1.23-1.57)、焦虑(OR 1.30,95% CI 1.15-1.47)、情绪障碍(OR 1.28,95% CI 1.13-1.44)、酒精或物质滥用障碍(OR 1.43,95% CI 1.12-1.84)和关节炎(OR 1.21,95% CI 1.10-1.34)。
手术后阿片类药物处方续用的概率与初始处方强度无关,这表明外科医生可以开具较小的处方而不会影响续用请求。未来研究可以检查疼痛、物质滥用和心理健康之间的相互作用,为患者的阿片类药物处方提供信息。